Atlas Trials

Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

Clinical trial NCT04937283 · RECRUITING

Trial details

NCT number
NCT04937283
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Lung Adenocarcinoma
Start date
2019-10-01
Primary completion
2028-12-30
Enrollment
690

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.